SIRT7 and cancer: It is therefore plausible that SIRT7, similar to its role in T cells, may regulate comparable metabolic pathways through similar molecular mechanisms in cancer cells to modulate BCAA utilization and, consequently, fine-tune the availability of these metabolites in the TME, ultimately influencing anti-cancer immunity.